Succinylsulfathiazole

CAS No. 116-43-8

Succinylsulfathiazole ( —— )

Catalog No. M10565 CAS No. 116-43-8

Succinylsulfathiazole is a sulfonamide, it is an ultra long acting drug.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 42 In Stock
100MG 37 In Stock
200MG Get Quote In Stock
500MG 83 In Stock
1G 126 In Stock

Biological Information

  • Product Name
    Succinylsulfathiazole
  • Note
    Research use only, not for human use.
  • Brief Description
    Succinylsulfathiazole is a sulfonamide, it is an ultra long acting drug.
  • Description
    Succinylsulfathiazole is a sulfonamide, it is an ultra long acting drug.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Autophagy
  • Target
    Autophagy
  • Recptor
    DHPS| DHPS
  • Research Area
    Infection
  • Indication
    ——

Chemical Information

  • CAS Number
    116-43-8
  • Formula Weight
    355.39
  • Molecular Formula
    C13H13N3O5S2
  • Purity
    >98% (HPLC)
  • Solubility
    Water: 10 mM
  • SMILES
    OC(=O)CCC(=O)NC1=CC=C(C=C1)S(=O)(=O)NC1=NC=CS1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.WRIGHT LD, SKEGGS HR. Am J Med Sci. 1946 Sep;212(3):312-4.
molnova catalog
related products
  • LYN-1604 2HCl 221675...

    LYN-1604 is a novel ULK1 activator.It inducing cell death involved in ATF3, RAD21, and caspase3, accompanied by autophagy and apoptosis.?LYN-1604, to be the best candidate for a ULK1 agonist.?LYN-1604 induced cell death involved in ATF3, RAD21, and caspase3, accompanied by autophagy and apoptosis.?LYN-1604 has potential for good therapeutic effects on TNBC by targeting ULK1-modulated cell death in vivo.

  • AMG PERK 44

    AMG PERK 44 is an orally active and selective PERK inhibitor (IC50: 6 nM) that induces autophagy. It also inhibits GCN2 (IC50: 7300 nM) and B-Raf (IC50 >1000 nM), making it useful for cancer research.

  • EACC

    EACC selectively inhibits the translocation of autophagosome-specific SNARE Stx17 thereby blocking autophagosome-lysosome fusion.?